Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · Real-Time Price · USD

1.890

-0.060 (-3.08%)

At close: Oct 10, 2025, 4:00 PM EDT

1.860

-0.030 (-1.59%)

After-hours: Oct 10, 2025, 6:46 PM EDT

Neumora Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	67.13	62.54	45.48	31.12
Research & Development	197.42	200.93	206.62	104.75
Total Operating Expenses	264.54	263.46	252.1	135.87
Operating Income	-264.54	-263.46	-252.1	-135.87
Interest Income	13.19	19.93	16.61	4.56
Other Non-Operating Income (Expense)	-	-0.08	-0.17	0.41
Total Non-Operating Income (Expense)	13.19	19.86	16.44	4.97
Pretax Income	-251.36	-243.61	-235.66	-130.9
Provision for Income Taxes	-	0.18	0.27	-
Net Income	-252.09	-243.79	-235.93	-130.9
Net Income to Common	-252.09	-243.79	-235.93	-130.9
Shares Outstanding (Basic)	161	159	65	27
Shares Outstanding (Diluted)	161	159	65	27
Shares Change (YoY)	24.41%	145.12%	138.99%	-
EPS (Basic)	-1.57	-1.53	-3.63	-4.81
EPS (Diluted)	-1.57	-1.53	-3.63	-4.81
Free Cash Flow	-195.68	-182.94	-163.4	-115.41
Free Cash Flow Per Share	-1.22	-1.15	-2.51	-4.24
EBITDA	-264.06	-262.83	-251.43	-135.28
EBIT	-264.54	-263.46	-252.1	-135.87
Effective Tax Rate	0.00%	-0.07%	-0.11%	0.00%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q